NCT06440850 2026-02-02
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
City of Hope Medical Center
Phase 2 Recruiting
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
NYU Langone Health
Bezmialem Vakif University
Elesta S.R.L.